Latest California Healthline Stories
President Donald Trump wants Congress to allot $500 million over 10 years for pediatric cancer research. While it’s welcomed by researchers and advocates, it’s not a lot of money.
Health was a featured player in President Donald Trump’s 2019 State of the Union address. The president set goals to bring down prescription drug prices, end the HIV epidemic in the U.S. and cure childhood cancer, among other things. Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News and Alice Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and, for “extra credit,” provide their favorite health policy stories of the week. Rovner also interviews KHN senior correspondent Phil Galewitz about the current “Bill of the Month” feature.
For some federal health programs, a shuttered government means business as usual. But the congressional impasse over funding will hit others hard.
KHN’s Mary Agnes Carey and Julie Rovner discuss some of the developments that shook up health news this week.
An NIH-funded network of hospitals uses advanced genetic science and nationwide collaboration to diagnose rare and sometimes undiscovered diseases.
Research institutions that stand to lose the most include UCSF, Stanford University and UC San Diego. Total NIH funding for the University of California system reached nearly $2 billion in fiscal year 2016.
In a paradox, researchers say testing for a vaccine will depend on the outbreak recurring this year.
Two prescription medications have been found to be successful in helping many patients with alcohol cravings. Yet they are rarely used and many patients don’t know they exist.